In situ Hybridization Market expected worth 739.9 Million USD by 2021 - PowerPoint PPT Presentation

About This Presentation
Title:

In situ Hybridization Market expected worth 739.9 Million USD by 2021

Description:

This market is expected to reach USD 739.9 Million by 2021 from USD 557.1 Million in 2016, growing at a CAGR of 5.8%. – PowerPoint PPT presentation

Number of Views:30

less

Transcript and Presenter's Notes

Title: In situ Hybridization Market expected worth 739.9 Million USD by 2021


1
MarketsandMarkets Presents
In situ Hybridization Market North American to
Offer Significant Growth Opportunities
http//www.marketsandmarkets.com/Market-Reports/in
-situ-hybridization-market-212028829.html
2
The report "In situ Hybridization Market by
Technique (FISH, CISH), Application (Cancer
Diagnosis, Neuroscience, Cytology, Infectious
Disease), End User (Molecular Diagnostic
Laboratories, Academic And Research Institutions)
- Global Forecast to 2021", This report studies
the global in situ hybridization market for the
forecast period of 2016 to 2021. This market is
expected to reach USD 739.9 Million by 2021 from
USD 557.1 Million in 2016, growing at a CAGR of
5.8. The global in situ hybridization market is
segmented on the basis of technique, application,
end user, and region. Browse 60 market data
tables 26 figures 195 pages and in-depth TOC on
"In situ Hybridization Market  Download The
PDF Brochure_at_ http//www.marketsandmarkets.com/pdf
download.asp?id212028829 The in situ
hybridization market is projected to reach USD
739.9 Million by 2021 from USD 557.1 Million in
2016, at a CAGR of 5.8 in the next five years
(2016 to 2021).
http//www.marketsandmarkets.com/Market-Reports/in
-situ-hybridization-market-212028829.html
3
The growth of the overall in situ hybridization
market can be attributed to the increasing
diagnosis and growing incidence prevalence of
cancer, technology advancements in therapeutics,
and increasing government initiatives
globally. Speak to Analyst_at_ http//www.marketsand
markets.com/speaktoanalyst.asp?id212028829 In
the coming years, the in situ hybridization
market is expected to witness the highest growth
in the Asia-Pacific region. This can be
attributed to the growing presence of
international players in China and India,
increasing cancer prevalence and diagnosis, and
increased healthcare expenditure across the
Asia-Pacific region are drivers for the in situ
hybridization market in this region. .  
httphttp//www.marketsandmarkets.com/Market-Report
s/in-situ-hybridization-market-212028829.html
4
North America is expected to account for the
largest share of the global in situ hybridization
market. This can be attributed to growing
clinical and research in cancer by biotechnology
and pharmaceutical companies, government
initiatives, increasing prevalence and diagnosis
of cancer in the U.S. and Canada, and increasing
adoption of companion diagnostics. Increased
adoption of companion diagnostics is attributed
to the development and launch of newer
therapeutic agents. In the U.S., the in situ
hybridization market is driven by increasing
government initiatives, growing biomedical
research, rising prevalence of cancer, and
growing demand for companion diagnostics and
personalized medicine.  In Canada, the growth of
the in situ hybridization market is driven by
increased government funding and growing
prevalence of cancer. The report segments in situ
hybridization market based on technique,
application, end user, and region.
http//www.marketsandmarkets.com/Market-Reports/in
-situ-hybridization-market-212028829.html
5
On the basis of technique, the global in situ
hybridization market is segmented into
fluorescent in situ hybridization (FISH) and
chromogenic in situ hybridization (CISH). The
FISH segment is expected to command the largest
share of the global in situ hybridization market,
by technique in 2016. This segment is also
projected to grow at the highest CAGR during the
forecast period (2016-2021). This can be
attributed to factors such as like high
resolution of this technique, rising adoption in
research activities laboratories to diagnose
cancer, chromosomal abnormalities, and infectious
diseases, among others. Abbott Laboratories,
Inc. (U.S.), F. Hoffmann-La Roche AG
(Switzerland), Leica Biosystems Nussloch GmbH
(Germany), Agilent Technologies (U.S.), Thermo
Fisher Scientific, Inc. (U.S.), Merck KGaA
(Germany), PerkinElmer, Inc. (U.S.), Exiqon A/S
(Denmark), BioGenex Laboratories, Inc. (U.S.),
Advanced Cell Diagnostics, Inc. (U.S.), and Bio
SB Inc. (U.S.) are some of the key players in the
in situ hybridization market worldwide.
http//www.marketsandmarkets.com/Market-Reports/in
-situ-hybridization-market-212028829.html
6
About MarketsandMarkets MarketsandMarkets
provides quantified B2B research on 30,000 high
growth niche opportunities/threats which will
impact 70 to 80 of worldwide companies
revenues. Currently servicing 5000 customers
worldwide including 80 of global Fortune 1000
companies as clients. Almost 75,000 top officers
across eight industries worldwide approach
MarketsandMarkets for their painpoints around
revenues decisions.   Our 850 fulltime analyst
and SMEs at MarketsandMarkets are tracking
global high growth markets following the "Growth
Engagement Model GEM". The GEM aims at
proactive collaboration with the clients to
identify new opportunities, identify most
important customers, write "Attack, avoid and
defend" strategies, identify sources of
incremental revenues for both the company and its
competitors. MarketsandMarkets now coming up
with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies,
innovators, strategic players) annually in high
growth emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve.   MarketsandMarketss flagship
competitive intelligence and market research
platform, "RT" connects over 200,000 markets and
entire value chains for deeper understanding of
the unmet insights along with market sizing and
forecasts of niche markets.   
http//http//www.marketsandmarkets.com/Market-Rep
orts/in-situ-hybridization-market-212028829.html
7
Contact Us
Mr. Rohan MarketsandMarkets 701 Pike Street
Suite 2175, Seattle, WA 98101, United States
Tel 1-888-600-6441 Email sales_at_marketsandmarket
s.com MarketsandMarkets Bloghttp//www.marketsan
dmarkets.comhttp//twitter.com/marketsmarkets htt
p//www.linkedin.com/company/marketsandmarkets
Write a Comment
User Comments (0)
About PowerShow.com